|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's range||50.26 - 50.82|
|52-week range||50.26 - 50.82|
|Beta (5Y monthly)||0.64|
|PE ratio (TTM)||N/A|
|Earnings date||06 Feb 2023 - 10 Feb 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||38.30|
NEW YORK, November 28, 2022--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Angela Hwang, Chief Commercial Officer, President, Global Biopharmaceuticals Business; Kevin Sullivan, Global Specialty Care & U.S. President; and Navin Katyal, U.S. Commercial and Global Business Lead for mRNA Portfolio, at the Evercore ISI HealthCONx Conference on Thursday, December 1, 2022 at 4:20 p.m. EST.
Hundreds of Americans die each day from COVID — and the unvaccinated make up a majority of those dead and hospitalized.
Healthcare reporter Anjalee Khemlani examines the warning the CDC and Dr. Anthony Fauci issued on imminent upticks in flu and upper respiratory disease ahead of the winter months, in addition to the efficacy data on Pfizer's latest BA.5 COVID-19 booster shot.